Purchase Order 75N93023P00950
Award Date
9/1/23
Potential Completion Date
8/31/24
Potential Value
$13K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
513210 - Software Publishers
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,579 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for Oxford Nanopore P2 SOLO reagents and supplies. Per the solicitation, NIH/NIAID sought quotes to procure Oxford Nanopore P2 SOLO reagents, supplies, and delivery to the specified location at NIH/NIAID in Bethesda, Maryland, in compliance with solicitation terms and conditions...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $12,500.00 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, for a license and warranty for a GridION instrument needed to support high throughput sequencing on HERVK and HIV projects. The award has an estimated completion date of April 23, 2025. There is no set-aside designation...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...
This $6,678 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company that develops and provides nanopore-based electronic DNA/RNA sequencing systems. The award does not have a set-aside designation. Through this contract, Oxford Nanopore is providing its next-generation sequencing equipment, consumables, and...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Oxford Nanopore Technologies Inc. for an annual software license and support renewal for the GridION platform. The potential value of this contract is $12,500.00, and it has a completion date of May 21, 2025. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit biotechnology company that develops...
Oxford Nanopore Technologies Inc. has been awarded a $12,500 firm fixed price purchase order by the National Institutes of Health's National Institute of Environmental Health Sciences to provide a license and device warranty for the Gridion Sequencer. The purchase order does not have a set-aside designation. Performance will take place in Research Triangle Park, North Carolina and run through January 31, 2025. The National Institute of Environmental Health Sciences conducts research on how the...
This $12,500.00 firm fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides a GridION license and warranty for the NHLBI's DNA Sequencing and Genomics Core Facility, with a period of performance from March 17, 2025, to March 16, 2026. Oxford Nanopore Technologies Inc. is a prime...
This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...